Stock listing
TNG Stock Price, News, Filings & Events — Transgene Sa
Selected listing: TNG · EURONEXT · EUR · FR
This page tracks Transgene Sa's TNG:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TNG:EURONEXT. TNG:EURONEXT is the stock-level entry point for investors researching Transgene Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Transgene SA is a public company listed on the French market under the ticker TNG, with a market capitalization of approximately €232.75 million. The company focuses on developing innovative immunotherapies for the treatment of cancer and infectious diseases. Transgene is committed to advancing its proprietary technologies to improve patient outcomes.
- Ticker
- TNG:EURONEXT
- Asset type
- Stock
- Market cap
- $272.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- EURONEXT
- Currency
- EUR
Transgene Sa TNG:EURONEXT stock context
This page tracks Transgene Sa's TNG:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TNG:EURONEXT. TNG:EURONEXT is the stock-level entry point for investors researching Transgene Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Transgene SA is a public company listed on the French market under the ticker TNG, with a market capitalization of approximately €232.75 million. The company focuses on developing innovative immunotherapies for the treatment of cancer and infectious diseases. Transgene is committed to advancing its proprietary technologies to improve patient outcomes.
Latest news from Transgene Sa
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2026
July 7, 2026
Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine
June 22, 2026
Transgene’s Combined General Meeting of May 22, 2026
May 22, 2026
Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026
May 4, 2026
Transgene Provides Business and Financial Update for Q1 2026
April 29, 2026
Transgene Sa earnings calls
Research Transgene Sa
Transgene Sa investor report
Review AI stock analysis and investor report context for TNG:EURONEXT.
Transgene Sa company profile
View the public company page for Transgene Sa on 6ix.
Transgene Sa news
Read company news and market updates connected to Transgene Sa.
Transgene Sa investor events
Find investor webinars, events, and replay context for Transgene Sa.
Alternate listings
TGNA:GETTEX
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
0OCQ:LSE
GB · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
913048:LSX
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
913048:LS
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TGNA:MUN
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TRGNF:OTC
US · USD
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TGNA:FWB
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TGNA:SWB
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TNGP:AQUISEU
GB · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TNGP:AQUISUK
GB · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TGNA:DUS
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.
TGNA:HAM
DE · EUR
Alternate listing for Transgene Sa; the primary context on this page is TNG:EURONEXT.